Table III.
Postoperative mortality and morbidity*
| Group |
||||
|---|---|---|---|---|
| Characteristic | Overall (%) | Statin | Control | P |
| 30-day mortality | 5 (2.6) | 2 | 3 | .51 |
| Overall morbidity | 40 (21) | 15 | 25 | .08 |
| Major morbidity | 6 (3.2) | 3 | 3 | .65 |
| Myocardial infarction | 3 (1.6) | 2 | 1 | .55 |
| Stroke | 0 (0) | 0 | 0 | N/A |
| Renal failure | 2 (1.1) | 0 | 2 | .25 |
| Pulmonary complications | 1 (0.5) | 1 | 0 | .50 |
| Other morbidities | ||||
| Early graft thrombosis | 7 (3.7) | 1 | 6 | .06 |
| Early amputation | 1 (0.5) | 0 | 1 | .32 |
| Cardiovascular (other) | ||||
| Congestive heart failure | 3 (1.6) | 2 | 1 | .50 |
| Arrythmia | 7 (3.7) | 3 | 4 | .51 |
| Gastrointestinal | ||||
| Cholecystitis | 2 (1) | 0 | 2 | .25 |
| Ischemic colitis | 2 (1) | 0 | 2 | .25 |
| Pancreatitis | 1 (0.5) | 0 | 1 | .32 |
| Deep venous thrombosis | 1 (0.5) | 1 | 0 | .50 |
| Wound infection | 15 (6.8) | 5 | 10 | .15 |
| Hematoma/seroma | 3 (1.6) | 1 | 2 | .50 |
*
All events occurred within 30 days of surgery.
Data shown as coded raw data (n) and percent.